0.009544
0.005510
0.000000
0.000000
0.011020
0.000000
0.000000
0.000000
0.003974
0.00000
0.00000
0.00000
Brown, N.R.
Petri, E.
Lowe, E.D.
Skamnaki, V.
Johnson, L.N.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
12
90.00
90.00
120.00
104.780
104.780
251.635
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C4 H10 N O6 P
199.099
n
PHOSPHOTHREONINE
PHOSPHONOTHREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
N
1
N
N
N
2
S
C
N
3
N
C
N
4
N
O
N
5
N
C
N
6
N
O
N
7
N
H
N
8
N
H
N
9
N
H
N
10
N
H
N
11
N
H
N
12
N
H
N
13
N
H
N
14
N
N
N
15
S
C
N
16
N
C
N
17
N
O
N
18
N
C
N
19
N
C
N
20
N
C
N
21
N
N
N
22
N
C
N
23
N
N
N
24
N
N
N
25
N
O
N
26
N
H
N
27
N
H
N
28
N
H
N
29
N
H
N
30
N
H
N
31
N
H
N
32
N
H
N
33
N
H
N
34
N
H
N
35
N
H
N
36
N
H
N
37
N
H
N
38
N
H
N
39
N
H
N
40
N
H
N
41
N
N
N
42
S
C
N
43
N
C
N
44
N
O
N
45
N
C
N
46
N
C
N
47
N
O
N
48
N
N
N
49
N
O
N
50
N
H
N
51
N
H
N
52
N
H
N
53
N
H
N
54
N
H
N
55
N
H
N
56
N
H
N
57
N
H
N
58
N
N
N
59
S
C
N
60
N
C
N
61
N
O
N
62
N
C
N
63
N
C
N
64
N
O
N
65
N
O
N
66
N
O
N
67
N
H
N
68
N
H
N
69
N
H
N
70
N
H
N
71
N
H
N
72
N
H
N
73
N
H
N
74
N
N
N
75
R
C
N
76
N
C
N
77
N
O
N
78
N
C
N
79
N
S
N
80
N
O
N
81
N
H
N
82
N
H
N
83
N
H
N
84
N
H
N
85
N
H
N
86
N
H
N
87
N
H
N
88
N
N
N
89
S
C
N
90
N
C
N
91
N
O
N
92
N
C
N
93
N
C
N
94
N
C
N
95
N
O
N
96
N
N
N
97
N
O
N
98
N
H
N
99
N
H
N
100
N
H
N
101
N
H
N
102
N
H
N
103
N
H
N
104
N
H
N
105
N
H
N
106
N
H
N
107
N
H
N
108
N
N
N
109
S
C
N
110
N
C
N
111
N
O
N
112
N
C
N
113
N
C
N
114
N
C
N
115
N
O
N
116
N
O
N
117
N
O
N
118
N
H
N
119
N
H
N
120
N
H
N
121
N
H
N
122
N
H
N
123
N
H
N
124
N
H
N
125
N
H
N
126
N
H
N
127
N
N
N
128
N
C
N
129
N
C
N
130
N
O
N
131
N
O
N
132
N
H
N
133
N
H
N
134
N
H
N
135
N
H
N
136
N
H
N
137
N
N
N
138
S
C
N
139
N
C
N
140
N
O
N
141
N
C
Y
142
N
C
Y
143
N
N
Y
144
N
C
Y
145
N
C
Y
146
N
N
N
147
N
O
N
148
N
H
N
149
N
H
N
150
N
H
N
151
N
H
N
152
N
H
N
153
N
H
N
154
N
H
N
155
N
H
N
156
N
H
N
157
N
H
N
158
N
O
N
159
N
H
N
160
N
H
N
161
N
N
N
162
S
C
N
163
N
C
N
164
N
O
N
165
S
C
N
166
N
C
N
167
N
C
N
168
N
C
N
169
N
O
N
170
N
H
N
171
N
H
N
172
N
H
N
173
N
H
N
174
N
H
N
175
N
H
N
176
N
H
N
177
N
H
N
178
N
H
N
179
N
H
N
180
N
H
N
181
N
H
N
182
N
H
N
183
N
N
N
184
S
C
N
185
N
C
N
186
N
O
N
187
N
C
N
188
N
C
N
189
N
C
N
190
N
C
N
191
N
O
N
192
N
H
N
193
N
H
N
194
N
H
N
195
N
H
N
196
N
H
N
197
N
H
N
198
N
H
N
199
N
H
N
200
N
H
N
201
N
H
N
202
N
H
N
203
N
H
N
204
N
H
N
205
N
N
N
206
S
C
N
207
N
C
N
208
N
O
N
209
N
C
N
210
N
C
N
211
N
C
N
212
N
C
N
213
N
N
N
214
N
O
N
215
N
H
N
216
N
H
N
217
N
H
N
218
N
H
N
219
N
H
N
220
N
H
N
221
N
H
N
222
N
H
N
223
N
H
N
224
N
H
N
225
N
H
N
226
N
H
N
227
N
H
N
228
N
H
N
229
N
H
N
230
N
N
N
231
S
C
N
232
N
C
N
233
N
O
N
234
N
C
N
235
N
C
N
236
N
S
N
237
N
C
N
238
N
O
N
239
N
H
N
240
N
H
N
241
N
H
N
242
N
H
N
243
N
H
N
244
N
H
N
245
N
H
N
246
N
H
N
247
N
H
N
248
N
H
N
249
N
H
N
250
N
N
N
251
S
C
N
252
N
C
N
253
N
O
N
254
N
C
Y
255
N
C
Y
256
N
C
Y
257
N
C
Y
258
N
C
Y
259
N
C
Y
260
N
C
N
261
N
O
N
262
N
H
N
263
N
H
N
264
N
H
N
265
N
H
N
266
N
H
N
267
N
H
N
268
N
H
N
269
N
H
N
270
N
H
N
271
N
H
N
272
N
H
N
273
N
N
N
274
S
C
N
275
N
C
N
276
N
O
N
277
N
C
N
278
N
C
N
279
N
C
N
280
N
O
N
281
N
H
N
282
N
H
N
283
N
H
N
284
N
H
N
285
N
H
N
286
N
H
N
287
N
H
N
288
N
H
N
289
N
H
N
290
N
N
N
291
S
C
N
292
N
C
N
293
N
O
N
294
N
C
N
295
N
O
N
296
N
O
N
297
N
H
N
298
N
H
N
299
N
H
N
300
N
H
N
301
N
H
N
302
N
H
N
303
N
H
N
304
N
N
N
305
S
C
N
306
N
C
N
307
N
O
N
308
R
C
N
309
N
O
N
310
N
C
N
311
N
O
N
312
N
H
N
313
N
H
N
314
N
H
N
315
N
H
N
316
N
H
N
317
N
H
N
318
N
H
N
319
N
H
N
320
N
H
N
321
N
N
N
322
S
C
N
323
R
C
N
324
N
C
N
325
N
O
N
326
N
P
N
327
N
O
N
328
N
O
N
329
N
O
N
330
N
C
N
331
N
O
N
332
N
O
N
333
N
H
N
334
N
H
N
335
N
H
N
336
N
H
N
337
N
H
N
338
N
H
N
339
N
H
N
340
N
H
N
341
N
H
N
342
N
H
N
343
N
N
N
344
S
C
N
345
N
C
N
346
N
O
N
347
N
C
Y
348
N
C
Y
349
N
C
Y
350
N
C
Y
351
N
N
Y
352
N
C
Y
353
N
C
Y
354
N
C
Y
355
N
C
Y
356
N
C
N
357
N
O
N
358
N
H
N
359
N
H
N
360
N
H
N
361
N
H
N
362
N
H
N
363
N
H
N
364
N
H
N
365
N
H
N
366
N
H
N
367
N
H
N
368
N
H
N
369
N
H
N
370
N
N
N
371
S
C
N
372
N
C
N
373
N
O
N
374
N
C
Y
375
N
C
Y
376
N
C
Y
377
N
C
Y
378
N
C
Y
379
N
C
Y
380
N
C
N
381
N
O
N
382
N
O
N
383
N
H
N
384
N
H
N
385
N
H
N
386
N
H
N
387
N
H
N
388
N
H
N
389
N
H
N
390
N
H
N
391
N
H
N
392
N
H
N
393
N
H
N
394
N
N
N
395
S
C
N
396
N
C
N
397
N
O
N
398
N
C
N
399
N
C
N
400
N
C
N
401
N
O
N
402
N
H
N
403
N
H
N
404
N
H
N
405
N
H
N
406
N
H
N
407
N
H
N
408
N
H
N
409
N
H
N
410
N
H
N
411
N
H
N
412
N
H
N
1
N
sing
N
2
N
sing
N
3
N
sing
N
4
N
sing
N
5
N
sing
N
6
N
sing
N
7
N
doub
N
8
N
sing
N
9
N
sing
N
10
N
sing
N
11
N
sing
N
12
N
sing
N
13
N
sing
N
14
N
sing
N
15
N
sing
N
16
N
sing
N
17
N
sing
N
18
N
sing
N
19
N
doub
N
20
N
sing
N
21
N
sing
N
22
N
sing
N
23
N
sing
N
24
N
sing
N
25
N
sing
N
26
N
sing
N
27
N
sing
N
28
N
sing
N
29
N
sing
N
30
N
sing
N
31
N
sing
N
32
N
sing
N
33
N
doub
N
34
N
sing
N
35
N
sing
N
36
N
sing
N
37
N
sing
N
38
N
sing
N
39
N
sing
N
40
N
sing
N
41
N
sing
N
42
N
sing
N
43
N
sing
N
44
N
sing
N
45
N
doub
N
46
N
sing
N
47
N
sing
N
48
N
sing
N
49
N
sing
N
50
N
doub
N
51
N
sing
N
52
N
sing
N
53
N
sing
N
54
N
sing
N
55
N
sing
N
56
N
sing
N
57
N
sing
N
58
N
sing
N
59
N
sing
N
60
N
sing
N
61
N
doub
N
62
N
sing
N
63
N
sing
N
64
N
sing
N
65
N
sing
N
66
N
doub
N
67
N
sing
N
68
N
sing
N
69
N
sing
N
70
N
sing
N
71
N
sing
N
72
N
sing
N
73
N
sing
N
74
N
sing
N
75
N
sing
N
76
N
doub
N
77
N
sing
N
78
N
sing
N
79
N
sing
N
80
N
sing
N
81
N
sing
N
82
N
sing
N
83
N
sing
N
84
N
sing
N
85
N
sing
N
86
N
sing
N
87
N
sing
N
88
N
sing
N
89
N
doub
N
90
N
sing
N
91
N
sing
N
92
N
sing
N
93
N
sing
N
94
N
sing
N
95
N
sing
N
96
N
sing
N
97
N
doub
N
98
N
sing
N
99
N
sing
N
100
N
sing
N
101
N
sing
N
102
N
sing
N
103
N
sing
N
104
N
sing
N
105
N
sing
N
106
N
sing
N
107
N
sing
N
108
N
doub
N
109
N
sing
N
110
N
sing
N
111
N
sing
N
112
N
sing
N
113
N
sing
N
114
N
sing
N
115
N
sing
N
116
N
doub
N
117
N
sing
N
118
N
sing
N
119
N
sing
N
120
N
sing
N
121
N
sing
N
122
N
sing
N
123
N
sing
N
124
N
sing
N
125
N
sing
N
126
N
doub
N
127
N
sing
N
128
N
sing
N
129
N
sing
N
130
N
sing
N
131
N
sing
N
132
N
sing
N
133
N
sing
N
134
N
sing
N
135
N
doub
N
136
N
sing
N
137
N
sing
N
138
N
sing
N
139
N
sing
Y
140
N
sing
Y
141
N
doub
Y
142
N
doub
N
143
N
sing
Y
144
N
sing
N
145
N
sing
Y
146
N
sing
N
147
N
sing
N
148
N
sing
N
149
N
sing
N
150
N
sing
N
151
N
sing
N
152
N
sing
N
153
N
sing
N
154
N
sing
N
155
N
sing
N
156
N
sing
N
157
N
sing
N
158
N
doub
N
159
N
sing
N
160
N
sing
N
161
N
sing
N
162
N
sing
N
163
N
sing
N
164
N
sing
N
165
N
sing
N
166
N
sing
N
167
N
sing
N
168
N
sing
N
169
N
sing
N
170
N
sing
N
171
N
sing
N
172
N
sing
N
173
N
sing
N
174
N
sing
N
175
N
sing
N
176
N
sing
N
177
N
sing
N
178
N
sing
N
179
N
doub
N
180
N
sing
N
181
N
sing
N
182
N
sing
N
183
N
sing
N
184
N
sing
N
185
N
sing
N
186
N
sing
N
187
N
sing
N
188
N
sing
N
189
N
sing
N
190
N
sing
N
191
N
sing
N
192
N
sing
N
193
N
sing
N
194
N
sing
N
195
N
sing
N
196
N
sing
N
197
N
sing
N
198
N
sing
N
199
N
sing
N
200
N
doub
N
201
N
sing
N
202
N
sing
N
203
N
sing
N
204
N
sing
N
205
N
sing
N
206
N
sing
N
207
N
sing
N
208
N
sing
N
209
N
sing
N
210
N
sing
N
211
N
sing
N
212
N
sing
N
213
N
sing
N
214
N
sing
N
215
N
sing
N
216
N
sing
N
217
N
sing
N
218
N
sing
N
219
N
sing
N
220
N
sing
N
221
N
sing
N
222
N
sing
N
223
N
sing
N
224
N
doub
N
225
N
sing
N
226
N
sing
N
227
N
sing
N
228
N
sing
N
229
N
sing
N
230
N
sing
N
231
N
sing
N
232
N
sing
N
233
N
sing
N
234
N
sing
N
235
N
sing
N
236
N
sing
N
237
N
sing
N
238
N
sing
N
239
N
sing
N
240
N
sing
N
241
N
sing
N
242
N
sing
N
243
N
doub
N
244
N
sing
N
245
N
sing
N
246
N
sing
N
247
N
sing
Y
248
N
doub
Y
249
N
sing
Y
250
N
sing
N
251
N
sing
Y
252
N
doub
N
253
N
sing
Y
254
N
doub
N
255
N
sing
Y
256
N
sing
N
257
N
sing
N
258
N
sing
N
259
N
sing
N
260
N
sing
N
261
N
sing
N
262
N
sing
N
263
N
sing
N
264
N
sing
N
265
N
sing
N
266
N
doub
N
267
N
sing
N
268
N
sing
N
269
N
sing
N
270
N
sing
N
271
N
sing
N
272
N
sing
N
273
N
sing
N
274
N
sing
N
275
N
sing
N
276
N
sing
N
277
N
sing
N
278
N
sing
N
279
N
sing
N
280
N
sing
N
281
N
sing
N
282
N
sing
N
283
N
doub
N
284
N
sing
N
285
N
sing
N
286
N
sing
N
287
N
sing
N
288
N
sing
N
289
N
sing
N
290
N
sing
N
291
N
sing
N
292
N
sing
N
293
N
sing
N
294
N
sing
N
295
N
sing
N
296
N
doub
N
297
N
sing
N
298
N
sing
N
299
N
sing
N
300
N
sing
N
301
N
sing
N
302
N
sing
N
303
N
sing
N
304
N
sing
N
305
N
sing
N
306
N
sing
N
307
N
sing
N
308
N
sing
N
309
N
sing
N
310
N
sing
N
311
N
sing
N
312
N
sing
N
313
N
sing
N
314
N
sing
N
315
N
sing
N
316
N
sing
N
317
N
sing
N
318
N
sing
N
319
N
doub
N
320
N
sing
N
321
N
sing
N
322
N
sing
N
323
N
sing
N
324
N
doub
N
325
N
sing
N
326
N
sing
N
327
N
sing
N
328
N
sing
N
329
N
sing
N
330
N
sing
N
331
N
sing
N
332
N
sing
N
333
N
doub
N
334
N
sing
N
335
N
sing
N
336
N
sing
N
337
N
sing
Y
338
N
doub
Y
339
N
sing
Y
340
N
sing
N
341
N
sing
Y
342
N
doub
Y
343
N
sing
Y
344
N
sing
N
345
N
sing
Y
346
N
sing
Y
347
N
doub
N
348
N
sing
Y
349
N
doub
N
350
N
sing
Y
351
N
sing
N
352
N
sing
N
353
N
sing
N
354
N
sing
N
355
N
sing
N
356
N
sing
N
357
N
sing
N
358
N
sing
N
359
N
sing
N
360
N
sing
N
361
N
doub
N
362
N
sing
N
363
N
sing
N
364
N
sing
N
365
N
sing
Y
366
N
doub
Y
367
N
sing
Y
368
N
sing
N
369
N
sing
Y
370
N
doub
N
371
N
sing
Y
372
N
doub
N
373
N
sing
Y
374
N
sing
N
375
N
sing
N
376
N
sing
N
377
N
sing
N
378
N
sing
N
379
N
sing
N
380
N
sing
N
381
N
sing
N
382
N
sing
N
383
N
sing
N
384
N
sing
N
385
N
doub
N
386
N
sing
N
387
N
sing
N
388
N
sing
N
389
N
sing
N
390
N
sing
N
391
N
sing
N
392
N
sing
N
393
N
sing
N
394
N
sing
N
395
N
sing
N
396
N
sing
US
Cell Cycle
1551-4005
6
1350
1359
10.4161/cc.6.11.4278
17495531
Cyclin B and cyclin A confer different substrate recognition properties on CDK2.
2007
10.2210/pdb2jgz/pdb
pdb_00002jgz
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
100.0
1
CCD
ADSC CCD
SINGLE WAVELENGTH
M
x-ray
1
0.87260
1.0
ID29
ESRF
0.87260
SYNCHROTRON
ESRF BEAMLINE ID29
PHOSPHORYLATED ON THR160
32999.125
CELL DIVISION PROTEIN KINASE 2
2.7.1.-
RESIDUES 1-288
1
man
polymer
30107.293
G2/MITOTIC-SPECIFIC CYCLIN-B1
RESIDUES 167-426
1
man
polymer
18.015
water
5
nat
water
P33 PROTEIN KINASE
CYCLIN B1
no
yes
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV
FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY
(TPO)HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD
YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV
FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY
THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS
FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD
A
polypeptide(L)
no
no
CSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQL
VGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYL
MELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYAT
SKHAKISTLPQLNSALVQDL
CSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQL
VGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYL
MELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYAT
SKHAKISTLPQLNSALVQDL
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
HUMAN
sample
9606
HOMO SAPIENS
562
ESCHERICHIA COLI
HUMAN
sample
9606
HOMO SAPIENS
562
ESCHERICHIA COLI
1
3.11
60.5
6.00
0.9-1.2 M AMMONIUM SULPHATE, 100 MM MES PH 6.0-6.5, 100 MM POTASSIUM CHLORIDE
citation
pdbx_database_status
struct_conn
chem_comp_atom
chem_comp_bond
database_2
pdbx_initial_refinement_model
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
Other
Data collection
Database references
Refinement description
1
0
2007-05-22
1
1
2011-05-08
1
2
2011-07-13
1
3
2019-10-09
1
4
2023-12-13
_citation.journal_id_ISSN
_citation.page_last
_citation.pdbx_database_id_DOI
_citation.title
_pdbx_database_status.status_code_sf
_struct_conn.pdbx_leaving_atom_flag
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR STAUROSPORINE
HUMAN CYCLIN-DEPENDENT KINASE 2
HUMAN CYCLIN-DEPENDENT KINASE 2 PHOSPHORYLATED ON THR 160
CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITHCELL CYCLE-REGULATORY PROTEIN CKSHS1
HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR PURVALANOL B
THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4-[3- HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE
HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR HYMENIALDISINE
HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU2058
HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU6027
THR 160 PHOSPHORYLATED CDK2 - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR INDIRUBIN-5- SULPHONATE BOUND
CRYSTAL STRUCTURE OF MURINE GAMMA HERPESVIRUS CYCLIN COMPLEXED TO HUMAN CYCLIN DEPENDANT KINASE 2
CYCLIN A - CYCLIN-DEPENDENT KINASE 2 COMPLEX
CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) INCOMPLEX WITH PHOSPHO-CDK2
THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) INCOMPLEX WITH AN OXINDOLE INHIBITOR
THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLEINHIBITOR
CRYSTAL STRUCTURE OF HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2)IN COMPLEX WITH THE INHIBITOR H717
HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR
HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR
HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR
PCDK2/CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE SUBSTRATE
HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 2-AMINO-6-(3'-METHYL- 2'-OXO)BUTOXYPURINE
CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 2-AMINO-6-[(R )-PYRROLIDINO-5'-YL]METHOXYPURINE
HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 2-AMINO-6-[ CYCLOHEX-3-ENYL]METHOXYPURINE
STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE INHIBITOR NU2058
STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE INHIBITOR NU6094
STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE INHIBITOR NU6086
STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE INHIBITOR NU6102
CDK2/CYCLINA IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM E2F
CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM E2F
CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P53
CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P27
CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P107
HUMAN CYCLIN-DEPENDENT KINASE 2
HUMAN CYCLIN-DEPENDENT KINASE 2
PHOSPHORYLATED CYCLIN-DEPENDENT KINASE-2 BOUND TO CYCLIN A
P27(KIP1)/CYCLIN A/CDK2 COMPLEX
THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) INCOMPLEX WITH 4-[(6-AMINO-4- PYRIMIDINYL)AMINO]BENZENESULFONAMIDE
CRYSTAL STRUCTURE OF HUMAN CDK2 ( UNPHOSPHORYLATED) INCOMPLEX WITH PKF049-365
CDK2 COMPLEXED WITH N-METHYL-4-{[(2-OXO- 1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL] AMINO}BENZENESULFONAMIDE
CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO -8H-[1,3]THIAZOLO[5,4-E]INDOL-8- YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE
CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2- BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3- OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2- ONE
CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3 -YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2- YL)BENZENESULFONAMIDE
CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[4-({[AMINO(IMINO)METHYL] AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3- DIHYDRO-1H-INDOLE
STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 2-ARYLAMINO-4- CYCLOHEXYLMETHYL-5-NITROSO-6-AMINOPYRIMIDINE INHIBITOR
STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION
IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION
IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION
STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ILE-PHE-NH2
CYCLIN A BINDING GROOVE INHIBITOR AC-ARG- ARG-LEU-ASN-(M-CL-PHE)-NH2
CYCLIN A BINDING GROOVE INHIBITOR H-CIT- CIT-LEU-ILE-(P-F-PHE)-NH2
CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ASN-(P-F-PHE)-NH2
THE STRUCTURE OF CYCLIN DEPENDENT KINASE 2 (CKD2) WITH ATRISUBSTITUTED NAPHTHOSTYRIL INHIBITOR
THE STRUCURE OF PHOSPHO-CDK2/CYCLIN A IN COMPLEX WITH THEINHIBITOR 4,5,6,7- TETRABROMOBENZOTRIAZOLE (TBS)
CRYSTAL STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2COMPLEXED WITH A NUCLEOSIDE INHIBITOR
THE CRYSTAL STRUCTURE OF UCN-01 IN COMPLEX WITH PHOSPHO-CDK2/CYCLIN A
APO STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2
HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-(2,5-DICHLORO-THIOPHEN- 3-YL)-PYRIMIDIN-2-YLAMINE
HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-(2,4-DIMETHYL-THIAZOL- 5-YL)-PYRIMIDIN-2-YLAMINE
HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR N-[4-(2,4-DIMETHYL- THIAZOL-5-YL)PYRIMIDIN-2-YL]-N'- HYDROXYIMINOFORMAMIDE
HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR [4-(2,4-DIMETHYL-THIAZOL- 5-YL)-PYRIMIDIN-2-YL]-(4-TRIFLUOROMETHYL- PHENYL)-AMINE
HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 3-[4-(2,4-DIMETHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YLAMINO]-PHENOL
HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-[4-(4-METHYL-2- METHYLAMINO-THIAZOL-5-YL)-PYRIMIDIN-2- YLAMINO]-PHENOL
HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR [4-(2-AMINO-4-METHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YL]-(3-NITRO- PHENYL)-AMINE
HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR N-[4-(2,4-DIMETHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'- DIMETHYL-BENZENE-1,4-DIAMINE
CRYSTAL STRUCTURE OF CDK2 WITH INHIBITOR
PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX
CDK2 COMPLEX WITH A 4-ALKYNYL OXINDOLE INHIBITOR
CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ASN-(P-F-PHE)-NH2
CDK2 IN COMPLEX WITH AN IMIDAZO[1,2-B] PYRIDAZINE
CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
STRUCTURE OF CDK2/CYCLIN A WITH PNU-292137
STRUCTURE OF CDK2 COMPLEXED WITH PNU-181227
CRYSTALS STRUCTURE OF HUMAN CDK2 IN COMPLEX WITH THE INHIBITOR OLOMOUCINE.
CO-CRYSTAL STRUCTURE OF 6-CYCLOHEXYLMETHOXY- 8-ISOPROPYL-9H-PURIN-2-YLAMINE AND MONOMERIC CDK2
THE STRUCTURAL BASIS OF CDK2 ACTIVATION BY CYCLIN E
SCREENING FOR FRAGMENT BINDING BY X-RAY CRYSTALLOGRAPHY
CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1,5-A]PYRIMIDINE INHIBITOR
CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1,5-A]PYRIMIDINE INHIBITOR
CRYSTAL STRUCTURE OF CDK2 WITH AN AMINOIMIDAZO PYRIDINEINHIBITOR
HUMAN CDK2 IN COMPLEX WITH OLOMOUCINE II, A NOVEL 2,6,9-TRISUBSTITUTED PURINE CYCLIN -DEPENDENT KINASE INHIBITOR
HUMAN CYCLIN-DEPENDENT KINASE 2 IN COMPLEX WITH ROSCOVITINE
HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DPH-042562
HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DIN-234325
HUMAN CYCLIN DEPENDENT KINASE 2 (CKD2) COMPLEXED WITH DIN-232305
HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITHINDENOPYRAXOLE DIN-101312
HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 5-BROMO- INDIRUBINE
HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 4- HYDROXYPIPERINDINESULFONYL-INDIRUBINE
STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611
STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529
STRUCTURE OF CDK2 COMPLEXED WITH PNU-198873
STRUCTURE OF CDK2 COMPLEXED WITH PNU-230032
STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514
DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA-LINKED ATP ANALOGUE
CRYSTAL STRUCTURE OF PHOSPHO-CDK2 CYCLIN A IN COMPLEX WITH A PEPTIDE CONTAINING BOTH THE SUBSTRATE AND RECRUITMENT SITES OF CDC6
MECHANISM OF CDK INHIBITION BY ACTIVE SITE PHOSPHORYLATION: CDK2 Y15P T160P IN COMPLEX WITH CYCLIN A STRUCTURE
4-ARYLAZO-3,5-DIAMINO-1H-PYRAZOLE CDK INHIBITORS: SAR STUDY, CRYSTAL STRUCTURE IN COMPLEX WITH CDK2, SELECTIVITY, AND CELLULAR EFFECTS
HUMAN CDK2 IN COMPLEX WITH ISOPENTENYLADENINE
STRUCTURE OF HUMAN THR160-PHOSPHO CDK2- CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR
STRUCTURE OF HUMAN THR160-PHOSPHO CDK2- CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR
STRUCTURE OF HUMAN THR160-PHOSPHO CDK2- CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR
CRYSTAL STRUCTURE OF CDK2 IN COMPLEX WITH MACROCYCLIC AMINOPYRIMIDINE
CRYSTAL STRUCTURE OF HUMAN CYCLIN B1
PDBE
Y
PDBE
2007-02-17
REL
REL
HOH
water
RESIDUE SER 0 DERIVES FROM THE EXPRESSION CONSTRUCT
A FRAGMENT CONTAINING RESIDUES 165-433 WAS USED IN THIS
STUDY
1QMZ
PDB ENTRY 1QMZ
PDB
experimental model
HOH
2001
3
HOH
HOH
2001
A
HOH
2002
3
HOH
HOH
2002
A
HOH
2003
3
HOH
HOH
2003
A
HOH
2001
3
HOH
HOH
2001
B
HOH
2002
3
HOH
HOH
2002
B
SER
0
n
1
SER
0
A
MET
1
n
2
MET
1
A
GLU
2
n
3
GLU
2
A
ASN
3
n
4
ASN
3
A
PHE
4
n
5
PHE
4
A
GLN
5
n
6
GLN
5
A
LYS
6
n
7
LYS
6
A
VAL
7
n
8
VAL
7
A
GLU
8
n
9
GLU
8
A
LYS
9
n
10
LYS
9
A
ILE
10
n
11
ILE
10
A
GLY
11
n
12
GLY
11
A
GLU
12
n
13
GLU
12
A
GLY
13
n
14
GLY
13
A
THR
14
n
15
THR
14
A
TYR
15
n
16
TYR
15
A
GLY
16
n
17
GLY
16
A
VAL
17
n
18
VAL
17
A
VAL
18
n
19
VAL
18
A
TYR
19
n
20
TYR
19
A
LYS
20
n
21
LYS
20
A
ALA
21
n
22
ALA
21
A
ARG
22
n
23
ARG
22
A
ASN
23
n
24
ASN
23
A
LYS
24
n
25
LYS
24
A
LEU
25
n
26
LEU
25
A
THR
26
n
27
THR
26
A
GLY
27
n
28
GLY
27
A
GLU
28
n
29
GLU
28
A
VAL
29
n
30
VAL
29
A
VAL
30
n
31
VAL
30
A
ALA
31
n
32
ALA
31
A
LEU
32
n
33
LEU
32
A
LYS
33
n
34
LYS
33
A
LYS
34
n
35
LYS
34
A
ILE
35
n
36
ILE
35
A
ARG
36
n
37
ARG
36
A
LEU
37
n
38
LEU
37
A
ASP
38
n
39
ASP
38
A
THR
39
n
40
THR
39
A
GLU
40
n
41
GLU
40
A
THR
41
n
42
THR
41
A
GLU
42
n
43
GLU
42
A
GLY
43
n
44
GLY
43
A
VAL
44
n
45
VAL
44
A
PRO
45
n
46
PRO
45
A
SER
46
n
47
SER
46
A
THR
47
n
48
THR
47
A
ALA
48
n
49
ALA
48
A
ILE
49
n
50
ILE
49
A
ARG
50
n
51
ARG
50
A
GLU
51
n
52
GLU
51
A
ILE
52
n
53
ILE
52
A
SER
53
n
54
SER
53
A
LEU
54
n
55
LEU
54
A
LEU
55
n
56
LEU
55
A
LYS
56
n
57
LYS
56
A
GLU
57
n
58
GLU
57
A
LEU
58
n
59
LEU
58
A
ASN
59
n
60
ASN
59
A
HIS
60
n
61
HIS
60
A
PRO
61
n
62
PRO
61
A
ASN
62
n
63
ASN
62
A
ILE
63
n
64
ILE
63
A
VAL
64
n
65
VAL
64
A
LYS
65
n
66
LYS
65
A
LEU
66
n
67
LEU
66
A
LEU
67
n
68
LEU
67
A
ASP
68
n
69
ASP
68
A
VAL
69
n
70
VAL
69
A
ILE
70
n
71
ILE
70
A
HIS
71
n
72
HIS
71
A
THR
72
n
73
THR
72
A
GLU
73
n
74
GLU
73
A
ASN
74
n
75
ASN
74
A
LYS
75
n
76
LYS
75
A
LEU
76
n
77
LEU
76
A
TYR
77
n
78
TYR
77
A
LEU
78
n
79
LEU
78
A
VAL
79
n
80
VAL
79
A
PHE
80
n
81
PHE
80
A
GLU
81
n
82
GLU
81
A
PHE
82
n
83
PHE
82
A
LEU
83
n
84
LEU
83
A
HIS
84
n
85
HIS
84
A
GLN
85
n
86
GLN
85
A
ASP
86
n
87
ASP
86
A
LEU
87
n
88
LEU
87
A
LYS
88
n
89
LYS
88
A
LYS
89
n
90
LYS
89
A
PHE
90
n
91
PHE
90
A
MET
91
n
92
MET
91
A
ASP
92
n
93
ASP
92
A
ALA
93
n
94
ALA
93
A
SER
94
n
95
SER
94
A
ALA
95
n
96
ALA
95
A
LEU
96
n
97
LEU
96
A
THR
97
n
98
THR
97
A
GLY
98
n
99
GLY
98
A
ILE
99
n
100
ILE
99
A
PRO
100
n
101
PRO
100
A
LEU
101
n
102
LEU
101
A
PRO
102
n
103
PRO
102
A
LEU
103
n
104
LEU
103
A
ILE
104
n
105
ILE
104
A
LYS
105
n
106
LYS
105
A
SER
106
n
107
SER
106
A
TYR
107
n
108
TYR
107
A
LEU
108
n
109
LEU
108
A
PHE
109
n
110
PHE
109
A
GLN
110
n
111
GLN
110
A
LEU
111
n
112
LEU
111
A
LEU
112
n
113
LEU
112
A
GLN
113
n
114
GLN
113
A
GLY
114
n
115
GLY
114
A
LEU
115
n
116
LEU
115
A
ALA
116
n
117
ALA
116
A
PHE
117
n
118
PHE
117
A
CYS
118
n
119
CYS
118
A
HIS
119
n
120
HIS
119
A
SER
120
n
121
SER
120
A
HIS
121
n
122
HIS
121
A
ARG
122
n
123
ARG
122
A
VAL
123
n
124
VAL
123
A
LEU
124
n
125
LEU
124
A
HIS
125
n
126
HIS
125
A
ARG
126
n
127
ARG
126
A
ASP
127
n
128
ASP
127
A
LEU
128
n
129
LEU
128
A
LYS
129
n
130
LYS
129
A
PRO
130
n
131
PRO
130
A
GLN
131
n
132
GLN
131
A
ASN
132
n
133
ASN
132
A
LEU
133
n
134
LEU
133
A
LEU
134
n
135
LEU
134
A
ILE
135
n
136
ILE
135
A
ASN
136
n
137
ASN
136
A
THR
137
n
138
THR
137
A
GLU
138
n
139
GLU
138
A
GLY
139
n
140
GLY
139
A
ALA
140
n
141
ALA
140
A
ILE
141
n
142
ILE
141
A
LYS
142
n
143
LYS
142
A
LEU
143
n
144
LEU
143
A
ALA
144
n
145
ALA
144
A
ASP
145
n
146
ASP
145
A
PHE
146
n
147
PHE
146
A
GLY
147
n
148
GLY
147
A
LEU
148
n
149
LEU
148
A
ALA
149
n
150
ALA
149
A
ARG
150
n
151
ARG
150
A
ALA
151
n
152
ALA
151
A
PHE
152
n
153
PHE
152
A
GLY
153
n
154
GLY
153
A
VAL
154
n
155
VAL
154
A
PRO
155
n
156
PRO
155
A
VAL
156
n
157
VAL
156
A
ARG
157
n
158
ARG
157
A
THR
158
n
159
THR
158
A
TYR
159
n
160
TYR
159
A
TPO
160
n
161
TPO
160
A
HIS
161
n
162
HIS
161
A
GLU
162
n
163
GLU
162
A
VAL
163
n
164
VAL
163
A
VAL
164
n
165
VAL
164
A
THR
165
n
166
THR
165
A
LEU
166
n
167
LEU
166
A
TRP
167
n
168
TRP
167
A
TYR
168
n
169
TYR
168
A
ARG
169
n
170
ARG
169
A
ALA
170
n
171
ALA
170
A
PRO
171
n
172
PRO
171
A
GLU
172
n
173
GLU
172
A
ILE
173
n
174
ILE
173
A
LEU
174
n
175
LEU
174
A
LEU
175
n
176
LEU
175
A
GLY
176
n
177
GLY
176
A
CYS
177
n
178
CYS
177
A
LYS
178
n
179
LYS
178
A
TYR
179
n
180
TYR
179
A
TYR
180
n
181
TYR
180
A
SER
181
n
182
SER
181
A
THR
182
n
183
THR
182
A
ALA
183
n
184
ALA
183
A
VAL
184
n
185
VAL
184
A
ASP
185
n
186
ASP
185
A
ILE
186
n
187
ILE
186
A
TRP
187
n
188
TRP
187
A
SER
188
n
189
SER
188
A
LEU
189
n
190
LEU
189
A
GLY
190
n
191
GLY
190
A
CYS
191
n
192
CYS
191
A
ILE
192
n
193
ILE
192
A
PHE
193
n
194
PHE
193
A
ALA
194
n
195
ALA
194
A
GLU
195
n
196
GLU
195
A
MET
196
n
197
MET
196
A
VAL
197
n
198
VAL
197
A
THR
198
n
199
THR
198
A
ARG
199
n
200
ARG
199
A
ARG
200
n
201
ARG
200
A
ALA
201
n
202
ALA
201
A
LEU
202
n
203
LEU
202
A
PHE
203
n
204
PHE
203
A
PRO
204
n
205
PRO
204
A
GLY
205
n
206
GLY
205
A
ASP
206
n
207
ASP
206
A
SER
207
n
208
SER
207
A
GLU
208
n
209
GLU
208
A
ILE
209
n
210
ILE
209
A
ASP
210
n
211
ASP
210
A
GLN
211
n
212
GLN
211
A
LEU
212
n
213
LEU
212
A
PHE
213
n
214
PHE
213
A
ARG
214
n
215
ARG
214
A
ILE
215
n
216
ILE
215
A
PHE
216
n
217
PHE
216
A
ARG
217
n
218
ARG
217
A
THR
218
n
219
THR
218
A
LEU
219
n
220
LEU
219
A
GLY
220
n
221
GLY
220
A
THR
221
n
222
THR
221
A
PRO
222
n
223
PRO
222
A
ASP
223
n
224
ASP
223
A
GLU
224
n
225
GLU
224
A
VAL
225
n
226
VAL
225
A
VAL
226
n
227
VAL
226
A
TRP
227
n
228
TRP
227
A
PRO
228
n
229
PRO
228
A
GLY
229
n
230
GLY
229
A
VAL
230
n
231
VAL
230
A
THR
231
n
232
THR
231
A
SER
232
n
233
SER
232
A
MET
233
n
234
MET
233
A
PRO
234
n
235
PRO
234
A
ASP
235
n
236
ASP
235
A
TYR
236
n
237
TYR
236
A
LYS
237
n
238
LYS
237
A
PRO
238
n
239
PRO
238
A
SER
239
n
240
SER
239
A
PHE
240
n
241
PHE
240
A
PRO
241
n
242
PRO
241
A
LYS
242
n
243
LYS
242
A
TRP
243
n
244
TRP
243
A
ALA
244
n
245
ALA
244
A
ARG
245
n
246
ARG
245
A
GLN
246
n
247
GLN
246
A
ASP
247
n
248
ASP
247
A
PHE
248
n
249
PHE
248
A
SER
249
n
250
SER
249
A
LYS
250
n
251
LYS
250
A
VAL
251
n
252
VAL
251
A
VAL
252
n
253
VAL
252
A
PRO
253
n
254
PRO
253
A
PRO
254
n
255
PRO
254
A
LEU
255
n
256
LEU
255
A
ASP
256
n
257
ASP
256
A
GLU
257
n
258
GLU
257
A
ASP
258
n
259
ASP
258
A
GLY
259
n
260
GLY
259
A
ARG
260
n
261
ARG
260
A
SER
261
n
262
SER
261
A
LEU
262
n
263
LEU
262
A
LEU
263
n
264
LEU
263
A
SER
264
n
265
SER
264
A
GLN
265
n
266
GLN
265
A
MET
266
n
267
MET
266
A
LEU
267
n
268
LEU
267
A
HIS
268
n
269
HIS
268
A
TYR
269
n
270
TYR
269
A
ASP
270
n
271
ASP
270
A
PRO
271
n
272
PRO
271
A
ASN
272
n
273
ASN
272
A
LYS
273
n
274
LYS
273
A
ARG
274
n
275
ARG
274
A
ILE
275
n
276
ILE
275
A
SER
276
n
277
SER
276
A
ALA
277
n
278
ALA
277
A
LYS
278
n
279
LYS
278
A
ALA
279
n
280
ALA
279
A
ALA
280
n
281
ALA
280
A
LEU
281
n
282
LEU
281
A
ALA
282
n
283
ALA
282
A
HIS
283
n
284
HIS
283
A
PRO
284
n
285
PRO
284
A
PHE
285
n
286
PHE
285
A
PHE
286
n
287
PHE
286
A
GLN
287
n
288
GLN
287
A
ASP
288
n
289
ASP
288
A
CYS
167
n
1
CYS
167
B
SER
168
n
2
SER
168
B
GLU
169
n
3
GLU
169
B
TYR
170
n
4
TYR
170
B
VAL
171
n
5
VAL
171
B
LYS
172
n
6
LYS
172
B
ASP
173
n
7
ASP
173
B
ILE
174
n
8
ILE
174
B
TYR
175
n
9
TYR
175
B
ALA
176
n
10
ALA
176
B
TYR
177
n
11
TYR
177
B
LEU
178
n
12
LEU
178
B
ARG
179
n
13
ARG
179
B
GLN
180
n
14
GLN
180
B
LEU
181
n
15
LEU
181
B
GLU
182
n
16
GLU
182
B
GLU
183
n
17
GLU
183
B
GLU
184
n
18
GLU
184
B
GLN
185
n
19
GLN
185
B
ALA
186
n
20
ALA
186
B
VAL
187
n
21
VAL
187
B
ARG
188
n
22
ARG
188
B
PRO
189
n
23
PRO
189
B
LYS
190
n
24
LYS
190
B
TYR
191
n
25
TYR
191
B
LEU
192
n
26
LEU
192
B
LEU
193
n
27
LEU
193
B
GLY
194
n
28
GLY
194
B
ARG
195
n
29
ARG
195
B
GLU
196
n
30
GLU
196
B
VAL
197
n
31
VAL
197
B
THR
198
n
32
THR
198
B
GLY
199
n
33
GLY
199
B
ASN
200
n
34
ASN
200
B
MET
201
n
35
MET
201
B
ARG
202
n
36
ARG
202
B
ALA
203
n
37
ALA
203
B
ILE
204
n
38
ILE
204
B
LEU
205
n
39
LEU
205
B
ILE
206
n
40
ILE
206
B
ASP
207
n
41
ASP
207
B
TRP
208
n
42
TRP
208
B
LEU
209
n
43
LEU
209
B
VAL
210
n
44
VAL
210
B
GLN
211
n
45
GLN
211
B
VAL
212
n
46
VAL
212
B
GLN
213
n
47
GLN
213
B
MET
214
n
48
MET
214
B
LYS
215
n
49
LYS
215
B
PHE
216
n
50
PHE
216
B
ARG
217
n
51
ARG
217
B
LEU
218
n
52
LEU
218
B
LEU
219
n
53
LEU
219
B
GLN
220
n
54
GLN
220
B
GLU
221
n
55
GLU
221
B
THR
222
n
56
THR
222
B
MET
223
n
57
MET
223
B
TYR
224
n
58
TYR
224
B
MET
225
n
59
MET
225
B
THR
226
n
60
THR
226
B
VAL
227
n
61
VAL
227
B
SER
228
n
62
SER
228
B
ILE
229
n
63
ILE
229
B
ILE
230
n
64
ILE
230
B
ASP
231
n
65
ASP
231
B
ARG
232
n
66
ARG
232
B
PHE
233
n
67
PHE
233
B
MET
234
n
68
MET
234
B
GLN
235
n
69
GLN
235
B
ASN
236
n
70
ASN
236
B
ASN
237
n
71
ASN
237
B
CYS
238
n
72
CYS
238
B
VAL
239
n
73
VAL
239
B
PRO
240
n
74
PRO
240
B
LYS
241
n
75
LYS
241
B
LYS
242
n
76
LYS
242
B
MET
243
n
77
MET
243
B
LEU
244
n
78
LEU
244
B
GLN
245
n
79
GLN
245
B
LEU
246
n
80
LEU
246
B
VAL
247
n
81
VAL
247
B
GLY
248
n
82
GLY
248
B
VAL
249
n
83
VAL
249
B
THR
250
n
84
THR
250
B
ALA
251
n
85
ALA
251
B
MET
252
n
86
MET
252
B
PHE
253
n
87
PHE
253
B
ILE
254
n
88
ILE
254
B
ALA
255
n
89
ALA
255
B
SER
256
n
90
SER
256
B
LYS
257
n
91
LYS
257
B
TYR
258
n
92
TYR
258
B
GLU
259
n
93
GLU
259
B
GLU
260
n
94
GLU
260
B
MET
261
n
95
MET
261
B
TYR
262
n
96
TYR
262
B
PRO
263
n
97
PRO
263
B
PRO
264
n
98
PRO
264
B
GLU
265
n
99
GLU
265
B
ILE
266
n
100
ILE
266
B
GLY
267
n
101
GLY
267
B
ASP
268
n
102
ASP
268
B
PHE
269
n
103
PHE
269
B
ALA
270
n
104
ALA
270
B
PHE
271
n
105
PHE
271
B
VAL
272
n
106
VAL
272
B
THR
273
n
107
THR
273
B
ASP
274
n
108
ASP
274
B
ASN
275
n
109
ASN
275
B
THR
276
n
110
THR
276
B
TYR
277
n
111
TYR
277
B
THR
278
n
112
THR
278
B
LYS
279
n
113
LYS
279
B
HIS
280
n
114
HIS
280
B
GLN
281
n
115
GLN
281
B
ILE
282
n
116
ILE
282
B
ARG
283
n
117
ARG
283
B
GLN
284
n
118
GLN
284
B
MET
285
n
119
MET
285
B
GLU
286
n
120
GLU
286
B
MET
287
n
121
MET
287
B
LYS
288
n
122
LYS
288
B
ILE
289
n
123
ILE
289
B
LEU
290
n
124
LEU
290
B
ARG
291
n
125
ARG
291
B
ALA
292
n
126
ALA
292
B
LEU
293
n
127
LEU
293
B
ASN
294
n
128
ASN
294
B
PHE
295
n
129
PHE
295
B
GLY
296
n
130
GLY
296
B
LEU
297
n
131
LEU
297
B
GLY
298
n
132
GLY
298
B
ARG
299
n
133
ARG
299
B
PRO
300
n
134
PRO
300
B
LEU
301
n
135
LEU
301
B
PRO
302
n
136
PRO
302
B
LEU
303
n
137
LEU
303
B
HIS
304
n
138
HIS
304
B
PHE
305
n
139
PHE
305
B
LEU
306
n
140
LEU
306
B
ARG
307
n
141
ARG
307
B
ARG
308
n
142
ARG
308
B
ALA
309
n
143
ALA
309
B
SER
310
n
144
SER
310
B
LYS
311
n
145
LYS
311
B
ILE
312
n
146
ILE
312
B
GLY
313
n
147
GLY
313
B
GLU
314
n
148
GLU
314
B
VAL
315
n
149
VAL
315
B
ASP
316
n
150
ASP
316
B
VAL
317
n
151
VAL
317
B
GLU
318
n
152
GLU
318
B
GLN
319
n
153
GLN
319
B
HIS
320
n
154
HIS
320
B
THR
321
n
155
THR
321
B
LEU
322
n
156
LEU
322
B
ALA
323
n
157
ALA
323
B
LYS
324
n
158
LYS
324
B
TYR
325
n
159
TYR
325
B
LEU
326
n
160
LEU
326
B
MET
327
n
161
MET
327
B
GLU
328
n
162
GLU
328
B
LEU
329
n
163
LEU
329
B
THR
330
n
164
THR
330
B
MET
331
n
165
MET
331
B
LEU
332
n
166
LEU
332
B
ASP
333
n
167
ASP
333
B
TYR
334
n
168
TYR
334
B
ASP
335
n
169
ASP
335
B
MET
336
n
170
MET
336
B
VAL
337
n
171
VAL
337
B
HIS
338
n
172
HIS
338
B
PHE
339
n
173
PHE
339
B
PRO
340
n
174
PRO
340
B
PRO
341
n
175
PRO
341
B
SER
342
n
176
SER
342
B
GLN
343
n
177
GLN
343
B
ILE
344
n
178
ILE
344
B
ALA
345
n
179
ALA
345
B
ALA
346
n
180
ALA
346
B
GLY
347
n
181
GLY
347
B
ALA
348
n
182
ALA
348
B
PHE
349
n
183
PHE
349
B
CYS
350
n
184
CYS
350
B
LEU
351
n
185
LEU
351
B
ALA
352
n
186
ALA
352
B
LEU
353
n
187
LEU
353
B
LYS
354
n
188
LYS
354
B
ILE
355
n
189
ILE
355
B
LEU
356
n
190
LEU
356
B
ASP
357
n
191
ASP
357
B
ASN
358
n
192
ASN
358
B
GLY
359
n
193
GLY
359
B
GLU
360
n
194
GLU
360
B
TRP
361
n
195
TRP
361
B
THR
362
n
196
THR
362
B
PRO
363
n
197
PRO
363
B
THR
364
n
198
THR
364
B
LEU
365
n
199
LEU
365
B
GLN
366
n
200
GLN
366
B
HIS
367
n
201
HIS
367
B
TYR
368
n
202
TYR
368
B
LEU
369
n
203
LEU
369
B
SER
370
n
204
SER
370
B
TYR
371
n
205
TYR
371
B
THR
372
n
206
THR
372
B
GLU
373
n
207
GLU
373
B
GLU
374
n
208
GLU
374
B
SER
375
n
209
SER
375
B
LEU
376
n
210
LEU
376
B
LEU
377
n
211
LEU
377
B
PRO
378
n
212
PRO
378
B
VAL
379
n
213
VAL
379
B
MET
380
n
214
MET
380
B
GLN
381
n
215
GLN
381
B
HIS
382
n
216
HIS
382
B
LEU
383
n
217
LEU
383
B
ALA
384
n
218
ALA
384
B
LYS
385
n
219
LYS
385
B
ASN
386
n
220
ASN
386
B
VAL
387
n
221
VAL
387
B
VAL
388
n
222
VAL
388
B
MET
389
n
223
MET
389
B
VAL
390
n
224
VAL
390
B
ASN
391
n
225
ASN
391
B
GLN
392
n
226
GLN
392
B
GLY
393
n
227
GLY
393
B
LEU
394
n
228
LEU
394
B
THR
395
n
229
THR
395
B
LYS
396
n
230
LYS
396
B
HIS
397
n
231
HIS
397
B
MET
398
n
232
MET
398
B
THR
399
n
233
THR
399
B
VAL
400
n
234
VAL
400
B
LYS
401
n
235
LYS
401
B
ASN
402
n
236
ASN
402
B
LYS
403
n
237
LYS
403
B
TYR
404
n
238
TYR
404
B
ALA
405
n
239
ALA
405
B
THR
406
n
240
THR
406
B
SER
407
n
241
SER
407
B
LYS
408
n
242
LYS
408
B
HIS
409
n
243
HIS
409
B
ALA
410
n
244
ALA
410
B
LYS
411
n
245
LYS
411
B
ILE
412
n
246
ILE
412
B
SER
413
n
247
SER
413
B
THR
414
n
248
THR
414
B
LEU
415
n
249
LEU
415
B
PRO
416
n
250
PRO
416
B
GLN
417
n
251
GLN
417
B
LEU
418
n
252
LEU
418
B
ASN
419
n
253
ASN
419
B
SER
420
n
254
SER
420
B
ALA
421
n
255
ALA
421
B
LEU
422
n
256
LEU
422
B
VAL
423
n
257
VAL
423
B
GLN
424
n
258
GLN
424
B
ASP
425
n
259
ASP
425
B
LEU
426
n
260
LEU
426
B
author_and_software_defined_assembly
PQS
2
dimeric
A
TPO
160
PHOSPHOTHREONINE
A
TPO
161
THR
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
ILE
10
A
N
ILE
11
A
O
VAL
18
A
O
VAL
19
A
N
ALA
21
A
N
ALA
22
A
O
VAL
30
A
O
VAL
31
A
N
ILE
35
A
N
ILE
36
A
O
LEU
76
A
O
LEU
77
A
O
VAL
79
A
O
VAL
80
A
N
LEU
67
A
N
LEU
68
A
N
GLN
85
A
N
GLN
86
A
O
ILE
135
A
O
ILE
136
A
N
LEU
134
A
N
LEU
135
A
O
LYS
142
A
O
LYS
143
A
N
LEU
124
A
N
LEU
125
A
O
ARG
150
A
O
ARG
151
1
A
A
OE1
NH2
GLU
ARG
57
122
2.02
1
A
A
THR
GLU
72
73
-149.52
1
A
ASN
59
-160.82
97.97
1
A
GLU
73
-20.71
38.49
1
A
ASN
74
-156.14
-14.88
1
A
SER
94
-83.82
36.06
1
A
ASP
127
-163.75
45.03
1
A
ASP
145
51.61
74.66
1
A
VAL
164
66.31
139.22
1
A
SER
181
-145.65
-153.45
1
A
ARG
199
78.21
-17.84
1
A
TRP
227
-150.39
75.84
1
A
SER
239
-63.93
25.07
1
A
ASP
256
-58.54
174.96
1
A
PHE
286
-91.85
39.88
1
A
GLN
287
-22.90
-88.04
1
B
GLN
185
-106.06
46.45
1
B
ARG
299
-38.88
123.33
1
B
ILE
312
-116.62
79.51
1
B
ASP
335
-59.52
-3.23
1
B
LEU
356
-103.82
-155.58
1
B
ASP
357
-28.89
-81.49
1
B
ASN
358
-150.74
-20.32
1
B
TRP
361
-66.59
84.73
1
B
LYS
411
40.11
28.49
1
B
LEU
415
-34.13
141.84
1
B
PRO
416
-63.09
76.25
1
B
LEU
418
-108.20
66.59
1
B
LEU
422
-81.74
49.36
1
B
VAL
423
-109.81
70.80
36.82
0.02000
0.01000
0.00000
0.02000
0.00000
-0.03000
0.923
0.864
HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS.
0.275
0.205
0.208
2.90
29.64
979
17963
5.200
99.9
15.137
0.294
RANDOM
1
THROUGHOUT
MOLECULAR REPLACEMENT
2.771
0.403
0.80
0.80
1.40
PDB ENTRY 1QMZ
MAXIMUM LIKELIHOOD
MASK
2.90
29.64
5
4437
0
0
4432
0.012
0.022
4535
1.442
1.974
6144
6.742
5.000
547
38.234
23.819
199
19.630
15.000
820
20.071
15.000
26
0.098
0.200
694
0.004
0.020
3359
0.231
0.200
2085
0.316
0.200
3151
0.171
0.200
127
0.246
0.200
35
0.180
0.200
3
0.682
1.500
2807
1.228
2.000
4457
1.514
3.000
1938
2.535
4.500
1687
0.3410
0.2720
2.98
74
1267
20
2.900
30.180
2JGZ
19123
2.000
0.12000
1
16.7000
8.800
99.9
0.52000
2.90
3.06
3.500
1
8.20
100.0
refinement
REFMAC
5.2.0019
data reduction
MOSFLM
data scaling
SCALA
phasing
PHASER
Crystal structure of phospho-CDK2 in complex with Cyclin B
1
N
N
2
N
N
3
N
N
3
N
N
A
PRO
45
A
PRO
46
HELX_P
A
LEU
58
A
LEU
59
1
1
14
A
LEU
87
A
LEU
88
HELX_P
A
SER
94
A
SER
95
1
2
8
A
PRO
100
A
PRO
101
HELX_P
A
SER
120
A
SER
121
1
3
21
A
LYS
129
A
LYS
130
HELX_P
A
GLN
131
A
GLN
132
5
4
3
A
THR
165
A
THR
166
HELX_P
A
ARG
169
A
ARG
170
5
5
5
A
ALA
170
A
ALA
171
HELX_P
A
LEU
175
A
LEU
176
1
6
6
A
THR
182
A
THR
183
HELX_P
A
ARG
199
A
ARG
200
1
7
18
A
SER
207
A
SER
208
HELX_P
A
GLY
220
A
GLY
221
1
8
14
A
GLY
229
A
GLY
230
HELX_P
A
MET
233
A
MET
234
5
9
5
A
ASP
247
A
ASP
248
HELX_P
A
VAL
252
A
VAL
253
1
10
6
A
ASP
256
A
ASP
257
HELX_P
A
MET
266
A
MET
267
1
11
11
A
SER
276
A
SER
277
HELX_P
A
LEU
281
A
LEU
282
1
12
6
A
ALA
282
A
ALA
283
HELX_P
A
GLN
287
A
GLN
288
5
13
6
B
TYR
170
B
TYR
4
HELX_P
B
GLN
185
B
GLN
19
1
14
16
B
THR
198
B
THR
32
HELX_P
B
ARG
217
B
ARG
51
1
15
20
B
LEU
219
B
LEU
53
HELX_P
B
GLN
235
B
GLN
69
1
16
17
B
PRO
240
B
PRO
74
HELX_P
B
LYS
242
B
LYS
76
5
17
3
B
MET
243
B
MET
77
HELX_P
B
GLU
260
B
GLU
94
1
18
18
B
GLU
265
B
GLU
99
HELX_P
B
THR
273
B
THR
107
1
19
9
B
THR
278
B
THR
112
HELX_P
B
ASN
294
B
ASN
128
1
20
17
B
LEU
301
B
LEU
135
HELX_P
B
ILE
312
B
ILE
146
1
21
12
B
ASP
316
B
ASP
150
HELX_P
B
MET
331
B
MET
165
1
22
16
B
LEU
332
B
LEU
166
HELX_P
B
VAL
337
B
VAL
171
5
23
6
B
PRO
340
B
PRO
174
HELX_P
B
LEU
356
B
LEU
190
1
24
17
B
THR
362
B
THR
196
HELX_P
B
LEU
369
B
LEU
203
1
25
8
B
THR
372
B
THR
206
HELX_P
B
GLN
392
B
GLN
226
1
26
21
B
MET
398
B
MET
232
HELX_P
B
TYR
404
B
TYR
238
1
27
7
B
THR
406
B
THR
240
HELX_P
B
ALA
410
B
ALA
244
5
28
5
B
LYS
411
B
LYS
245
HELX_P
B
LEU
415
B
LEU
249
5
29
5
covale
1.320
both
A
TYR
159
A
C
TYR
160
1_555
A
TPO
160
A
N
TPO
161
1_555
covale
1.331
both
A
TPO
160
A
C
TPO
161
1_555
A
HIS
161
A
N
HIS
162
1_555
TRANSFERASE
PROTEIN KINASE, UBL CONJUGATION, PHOSPHORYLATION, SERINE/THREONINE-PROTEIN KINASE, KINASE, CYCLIN, MITOSIS, CELL CYCLE, TRANSFERASE, ATP-BINDING, POLYMORPHISM, CELL DIVISION, NUCLEOTIDE-BINDING, SUBSTRATE SPECIFICITY
A
VAL
154
A
VAL
155
1
A
PRO
155
A
PRO
156
7.59
B
ILE
312
B
ILE
146
1
B
GLY
313
B
GLY
147
-3.48
B
GLY
313
B
GLY
147
1
B
GLU
314
B
GLU
148
-3.26
B
ASP
357
B
ASP
191
1
B
ASN
358
B
ASN
192
-14.05
B
ASP
425
B
ASP
259
1
B
LEU
426
B
LEU
260
-12.31
2JGZ
PDB
1
2JGZ
CDK2_HUMAN
UNP
1
P24941
CCNB1_HUMAN
UNP
2
P14635
0
0
2JGZ
0
0
2JGZ
A
1
1
1
1
288
2JGZ
1
288
P24941
A
2
2
289
167
426
2JGZ
167
426
P14635
B
3
1
260
5
3
2
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
PHE
4
A
PHE
5
A
GLU
12
A
GLU
13
A
VAL
17
A
VAL
18
A
ASN
23
A
ASN
24
A
VAL
29
A
VAL
30
A
ARG
36
A
ARG
37
A
LYS
75
A
LYS
76
A
GLU
81
A
GLU
82
A
LEU
66
A
LEU
67
A
THR
72
A
THR
73
A
GLN
85
A
GLN
86
A
ASP
86
A
ASP
87
A
LEU
133
A
LEU
134
A
ILE
135
A
ILE
136
A
ILE
141
A
ILE
142
A
LEU
143
A
LEU
144
A
VAL
123
A
VAL
124
A
LEU
124
A
LEU
125
A
ARG
150
A
ARG
151
A
ALA
151
A
ALA
152
178
P 61 2 2